Mercurial > repos > proteore > proteore_expression_rnaseq_abbased

comparison test-data/Get_annotation_RNAseq.txt @ 11:e109cacd75b2 draft

Find changesets by keywords (author, files, the commit message), revision number or hash, or revset expression.
planemo upload commit f91a292f92a3e75996e6f4502fa090961727c235-dirty
author proteore
date Wed, 02 Jan 2019 04:40:04 -0500
parents 8dd24f13f923
children
comparison
equal deleted inserted replaced
10:7b9a4ec7ec54 11:e109cacd75b2
1 Ensembl gene ids Protein.accession.number..UniProt. Protein.name Number.of.peptides..razor...unique. neXtProt_ID UniProt.ID GeneID MIM Gene Gene.description Evidence Antibody RNA.tissue.category Subcellular.location RNA.TS.TPM TPM.max.in.non.specific 1 Protein accession number (UniProt) Protein name Number of peptides (razor + unique) neXtProt_ID UniProt.ID GeneID MIM Ensembl Gene Gene description Evidence Antibody RNA tissue category Reliability (IH) Reliability (IF) Subcellular location RNA TS TPM TPM max in non-specific
2 ENSG00000005893 P13473 Lysosome-associated membrane glycoprotein 2 2 NX_P13473 LAMP2_HUMAN 3920 300257; 309060 LAMP2 Lysosomal-associated membrane protein 2 Evidence at protein level CAB005272, HPA029100 Expressed in all NA NA gallbladder: 223.9 2 P13473 Lysosome-associated membrane glycoprotein 2 2 NX_P13473 LAMP2_HUMAN 3920 300257; 309060 ENSG00000005893 LAMP2 Lysosomal-associated membrane protein 2 Evidence at protein level CAB005272, HPA029100 Expressed in all Supported NA NA NA gallbladder: 223.9
3 ENSG00000006625 O75223 Gamma-glutamylcyclotransferase 6 NX_O75223 GGCT_HUMAN 79017 137170 GGCT Gamma-glutamylcyclotransferase Evidence at protein level HPA020735, HPA029914 Expressed in all NA NA epididymis: 123.9 3 O75223 Gamma-glutamylcyclotransferase 6 NX_O75223 GGCT_HUMAN 79017 137170 ENSG00000006625 GGCT Gamma-glutamylcyclotransferase Evidence at protein level HPA020735, HPA029914 Expressed in all Approved NA NA NA epididymis: 123.9
4 ENSG00000012223 P02788 Lactotransferrin 21 NX_P02788 TRFL_HUMAN 4057 150210 LTF Lactotransferrin Evidence at protein level CAB008646, CAB016201, HPA057177, HPA059976 Tissue enhanced NA bone marrow: 2808.6;cervix, uterine: 1024.2 seminal vesicle: 526.7 4 P02788 Lactotransferrin 21 NX_P02788 TRFL_HUMAN 4057 150210 ENSG00000012223 LTF Lactotransferrin Evidence at protein level CAB008646, CAB016201, HPA057177, HPA059976 Tissue enhanced Supported NA NA bone marrow: 2808.6;cervix, uterine: 1024.2 seminal vesicle: 526.7
5 ENSG00000014216 P07384 Calpain-1 catalytic subunit 4 NX_P07384 CAN1_HUMAN 823 114220; 616907 CAPN1 Calpain 1, (mu/I) large subunit Evidence at protein level HPA005992 Expressed in all Cytosol NA esophagus: 245.3 5 P07384 Calpain-1 catalytic subunit 4 NX_P07384 CAN1_HUMAN 823 114220; 616907 ENSG00000014216 CAPN1 Calpain 1, (mu/I) large subunit Evidence at protein level HPA005992 Expressed in all Supported Supported Cytosol NA esophagus: 245.3
6 ENSG00000021355 P30740 Leukocyte elastase inhibitor 3 NX_P30740 ILEU_HUMAN 1992 130135 SERPINB1 Serpin peptidase inhibitor, clade B (ovalbumin), member 1 Evidence at protein level HPA018871, HPA052642 Expressed in all NA NA esophagus: 466.2 6 P30740 Leukocyte elastase inhibitor 3 NX_P30740 ILEU_HUMAN 1992 130135 ENSG00000021355 SERPINB1 Serpin peptidase inhibitor, clade B (ovalbumin), member 1 Evidence at protein level HPA018871, HPA052642 Expressed in all Supported NA NA NA esophagus: 466.2
7 ENSG00000025708 P19971 Thymidine phosphorylase 2 NX_P19971 TYPH_HUMAN 1890 131222; 603041 TYMP Thymidine phosphorylase Evidence at protein level HPA000530, HPA001072, CAB002518 Tissue enhanced Nuclear bodies<br>Golgi apparatus appendix: 103.2 spleen: 54.0 7 P19971 Thymidine phosphorylase 2 NX_P19971 TYPH_HUMAN 1890 131222; 603041 ENSG00000025708 TYMP Thymidine phosphorylase Evidence at protein level HPA000530, HPA001072, CAB002518 Tissue enhanced Approved Approved Nuclear bodies<br>Golgi apparatus appendix: 103.2 spleen: 54.0
8 ENSG00000035403 P18206 Vinculin 4 NX_P18206 VINC_HUMAN 7414 193065; 611407; 613255 VCL Vinculin Evidence at protein level HPA002131, CAB002453, HPA063777 Expressed in all Focal adhesion sites NA smooth muscle: 339.0 8 P18206 Vinculin 4 NX_P18206 VINC_HUMAN 7414 193065; 611407; 613255 ENSG00000035403 VCL Vinculin Evidence at protein level HPA002131, CAB002453, HPA063777 Expressed in all Supported Validated Focal adhesion sites NA smooth muscle: 339.0
9 ENSG00000038002 P20933 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase 3 NX_P20933 ASPG_HUMAN 175 208400; 613228 AGA Aspartylglucosaminidase Evidence at protein level HPA031415, HPA031417 Expressed in all NA NA epididymis: 34.7 9 P20933 N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase 3 NX_P20933 ASPG_HUMAN 175 208400; 613228 ENSG00000038002 AGA Aspartylglucosaminidase Evidence at protein level HPA031415, HPA031417 Expressed in all Supported NA NA NA epididymis: 34.7
10 ENSG00000042493 P40121 Macrophage-capping protein 2 NX_P40121 CAPG_HUMAN 822 153615 CAPG Capping protein (actin filament), gelsolin-like Evidence at protein level HPA018843, HPA019080, HPA019092 Expressed in all Nucleus NA parathyroid gland: 233.4 10 P40121 Macrophage-capping protein 2 NX_P40121 CAPG_HUMAN 822 153615 ENSG00000042493 CAPG Capping protein (actin filament), gelsolin-like Evidence at protein level HPA018843, HPA019080, HPA019092 Expressed in all Supported Validated Nucleus NA parathyroid gland: 233.4
11 ENSG00000044574 P11021 78 kDa glucose-regulated protein 10 NX_P11021 GRP78_HUMAN 3309 138120 HSPA5 Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) Evidence at protein level CAB005221, HPA038845, HPA038846 Expressed in all Cytosol NA thyroid gland: 965.5 11 P11021 78 kDa glucose-regulated protein 10 NX_P11021 GRP78_HUMAN 3309 138120 ENSG00000044574 HSPA5 Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) Evidence at protein level CAB005221, HPA038845, HPA038846 Expressed in all Supported Supported Cytosol NA thyroid gland: 965.5
12 ENSG00000057149 P29508 Serpin B3 20 NX_P29508 SPB3_HUMAN 6317 600517 SERPINB3 Serpin peptidase inhibitor, clade B (ovalbumin), member 3 Evidence at protein level CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992 Group enriched Plasma membrane<br>Cytosol cervix, uterine: 297.6;esophagus: 851.2 urinary bladder: 90.5 12 P29508 Serpin B3 20 NX_P29508 SPB3_HUMAN 6317 600517 ENSG00000057149 SERPINB3 Serpin peptidase inhibitor, clade B (ovalbumin), member 3 Evidence at protein level CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992 Group enriched Supported Approved Plasma membrane<br>Cytosol cervix, uterine: 297.6;esophagus: 851.2 urinary bladder: 90.5
13 ENSG00000057608 P50395 Rab GDP dissociation inhibitor beta 2 NX_P50395 GDIB_HUMAN 2665 600767 GDI2 GDP dissociation inhibitor 2 Evidence at protein level HPA049290, HPA057668 Expressed in all NA NA lymph node: 244.2 13 P50395 Rab GDP dissociation inhibitor beta 2 NX_P50395 GDIB_HUMAN 2665 600767 ENSG00000057608 GDI2 GDP dissociation inhibitor 2 Evidence at protein level HPA049290, HPA057668 Expressed in all Supported NA NA NA lymph node: 244.2
14 ENSG00000067225 P14618 Pyruvate kinase PKM 9 NX_P14618 KPYM_HUMAN 5315 179050 PKM Pyruvate kinase, muscle Evidence at protein level CAB019421, HPA029501 Expressed in all Cytosol NA skeletal muscle: 1492.7 14 P14618 Pyruvate kinase PKM 9 NX_P14618 KPYM_HUMAN 5315 179050 ENSG00000067225 PKM Pyruvate kinase, muscle Evidence at protein level CAB019421, HPA029501 Expressed in all Uncertain Validated Cytosol NA skeletal muscle: 1492.7
15 ENSG00000074800 P06733 Alpha-enolase 15 NX_P06733 ENOA_HUMAN 2023 172430 ENO1 Enolase 1, (alpha) Evidence at protein level CAB018614, HPA068284, CAB069394 Expressed in all Nucleoplasm<br>Plasma membrane<br>Cytosol NA appendix: 789.1 15 P06733 Alpha-enolase 15 NX_P06733 ENOA_HUMAN 2023 172430 ENSG00000074800 ENO1 Enolase 1, (alpha) Evidence at protein level CAB018614, HPA068284, CAB069394 Expressed in all Supported Validated Nucleoplasm<br>Plasma membrane<br>Cytosol NA appendix: 789.1
16 ENSG00000077549 P47756 F-actin-capping protein subunit beta 2 NX_P47756 CAPZB_HUMAN 832 601572 CAPZB Capping protein (actin filament) muscle Z-line, beta Evidence at protein level HPA031531, HPA056066 Expressed in all Nucleoplasm<br>Vesicles<br>Cytosol NA smooth muscle: 484.4 16 P47756 F-actin-capping protein subunit beta 2 NX_P47756 CAPZB_HUMAN 832 601572 ENSG00000077549 CAPZB Capping protein (actin filament) muscle Z-line, beta Evidence at protein level HPA031531, HPA056066 Expressed in all Approved Validated Nucleoplasm<br>Vesicles<br>Cytosol NA smooth muscle: 484.4
17 ENSG00000080824 P07900 Heat shock protein HSP 90-alpha 6 NX_P07900 HS90A_HUMAN 3320 140571 HSP90AA1 Heat shock protein 90kDa alpha (cytosolic), class A member 1 Evidence at protein level CAB002058 Expressed in all Cytosol NA cerebral cortex: 1024.3 17 P07900 Heat shock protein HSP 90-alpha 6 NX_P07900 HS90A_HUMAN 3320 140571 ENSG00000080824 HSP90AA1 Heat shock protein 90kDa alpha (cytosolic), class A member 1 Evidence at protein level CAB002058 Expressed in all Approved Supported Cytosol NA cerebral cortex: 1024.3
18 ENSG00000084110 P42357 Histidine ammonia-lyase 2 NX_P42357 HUTH_HUMAN 3034 235800; 609457 HAL Histidine ammonia-lyase Evidence at protein level HPA038547, HPA038548 Group enriched Cytosol liver: 51.0;skin: 72.6 bone marrow: 7.4 18 P42357 Histidine ammonia-lyase 2 NX_P42357 HUTH_HUMAN 3034 235800; 609457 ENSG00000084110 HAL Histidine ammonia-lyase Evidence at protein level HPA038547, HPA038548 Group enriched Supported Uncertain Cytosol liver: 51.0;skin: 72.6 bone marrow: 7.4
19 ENSG00000084207 P09211 Glutathione S-transferase P 4 NX_P09211 GSTP1_HUMAN 2950 134660 GSTP1 Glutathione S-transferase pi 1 Evidence at protein level HPA019779, HPA019869 Expressed in all Mitochondria<br>Cytosol NA esophagus: 1064.0 19 P09211 Glutathione S-transferase P 4 NX_P09211 GSTP1_HUMAN 2950 134660 ENSG00000084207 GSTP1 Glutathione S-transferase pi 1 Evidence at protein level HPA019779, HPA019869 Expressed in all Approved Supported Mitochondria<br>Cytosol NA esophagus: 1064.0
20 ENSG00000090382 P61626 Lysozyme C 7 NX_P61626 LYSC_HUMAN 4069 105200; 153450 LYZ Lysozyme Evidence at protein level CAB000055, HPA048284 Expressed in all NA NA stomach: 9772.4 20 P61626 Lysozyme C 7 NX_P61626 LYSC_HUMAN 4069 105200; 153450 ENSG00000090382 LYZ Lysozyme Evidence at protein level CAB000055, HPA048284 Expressed in all Supported NA NA NA stomach: 9772.4
21 ENSG00000091513 P02787 Serotransferrin 9 NX_P02787 TRFE_HUMAN 7018 190000; 209300 TF Transferrin Evidence at protein level HPA001527, HPA005692, CAB009538 Tissue enriched Mitochondria liver: 5384.6 cerebral cortex: 386.9 21 P02787 Serotransferrin 9 NX_P02787 TRFE_HUMAN 7018 190000; 209300 ENSG00000091513 TF Transferrin Evidence at protein level HPA001527, HPA005692, CAB009538 Tissue enriched Supported Uncertain Mitochondria liver: 5384.6 cerebral cortex: 386.9
22 ENSG00000096696 P15924 Desmoplakin 69 NX_P15924 DESP_HUMAN 1832 125647; 605676; 607450; 607655; 609638; 612908; 615821 DSP Desmoplakin Evidence at protein level CAB037324, HPA045840, HPA054950 Group enriched Cell Junctions esophagus: 346.9;skin: 1019.0 placenta: 88.5 22 P15924 Desmoplakin 69 NX_P15924 DESP_HUMAN 1832 125647; 605676; 607450; 607655; 609638; 612908; 615821 ENSG00000096696 DSP Desmoplakin Evidence at protein level CAB037324, HPA045840, HPA054950 Group enriched Supported Validated Cell Junctions esophagus: 346.9;skin: 1019.0 placenta: 88.5
23 ENSG00000100345 P35579 Myosin-9 8 NX_P35579 MYH9_HUMAN 4627 153640; 153650; 155100; 160775; 600208; 603622; 605249 MYH9 Myosin, heavy chain 9, non-muscle Evidence at protein level HPA001644, CAB015386 Expressed in all Plasma membrane<br>Actin filaments<br>Cytosol NA spleen: 313.7 23 P35579 Myosin-9 8 NX_P35579 MYH9_HUMAN 4627 153640; 153650; 155100; 160775; 600208; 603622; 605249 ENSG00000100345 MYH9 Myosin, heavy chain 9, non-muscle Evidence at protein level HPA001644, CAB015386 Expressed in all Supported Approved Plasma membrane<br>Actin filaments<br>Cytosol NA spleen: 313.7
24 ENSG00000100567 P25788 Proteasome subunit alpha type-3 3 NX_P25788 PSA3_HUMAN 5684 176843; 176845 PSMA3 Proteasome subunit alpha 3 Evidence at protein level HPA000905 Expressed in all NA NA epididymis: 149.3 24 P25788 Proteasome subunit alpha type-3 3 NX_P25788 PSA3_HUMAN 5684 176843; 176845 ENSG00000100567 PSMA3 Proteasome subunit alpha 3 Evidence at protein level HPA000905 Expressed in all Approved NA NA NA epididymis: 149.3
25 ENSG00000100983 P48637 Glutathione synthetase 2 NX_P48637 GSHB_HUMAN 2937 231900; 266130; 601002 GSS Glutathione synthetase Evidence at protein level HPA054508, HPA059315 Expressed in all Nucleus NA epididymis: 104.1 25 P48637 Glutathione synthetase 2 NX_P48637 GSHB_HUMAN 2937 231900; 266130; 601002 ENSG00000100983 GSS Glutathione synthetase Evidence at protein level HPA054508, HPA059315 Expressed in all Supported Supported Nucleus NA epididymis: 104.1
26 ENSG00000101441 P01036 Cystatin-S 5 NX_P01036 CYTS_HUMAN 1472 123857 CST4 Cystatin S Evidence at protein level HPA043706, HPA044763 Tissue enriched NA salivary gland: 9974.9 gallbladder: 88.0 26 P01036 Cystatin-S 5 NX_P01036 CYTS_HUMAN 1472 123857 ENSG00000101441 CST4 Cystatin S Evidence at protein level HPA043706, HPA044763 Tissue enriched Supported NA NA salivary gland: 9974.9 gallbladder: 88.0
27 ENSG00000102144 P00558 Phosphoglycerate kinase 1 4 NX_P00558 PGK1_HUMAN 5230 300653; 311800 PGK1 Phosphoglycerate kinase 1 Evidence at protein level CAB010065, HPA045385 Expressed in all NA NA parathyroid gland: 116.6 27 P00558 Phosphoglycerate kinase 1 4 NX_P00558 PGK1_HUMAN 5230 300653; 311800 ENSG00000102144 PGK1 Phosphoglycerate kinase 1 Evidence at protein level CAB010065, HPA045385 Expressed in all Approved NA NA NA parathyroid gland: 116.6
28 ENSG00000105141 P31944 Caspase-14 15 NX_P31944 CASPE_HUMAN 23581 605848; 617320 CASP14 Caspase 14, apoptosis-related cysteine peptidase Evidence at protein level CAB010059, HPA027062 Tissue enriched Cytosol skin: 560.0 breast: 10.0 28 P31944 Caspase-14 15 NX_P31944 CASPE_HUMAN 23581 605848; 617320 ENSG00000105141 CASP14 Caspase 14, apoptosis-related cysteine peptidase Evidence at protein level CAB010059, HPA027062 Tissue enriched Supported Supported Cytosol skin: 560.0 breast: 10.0
29 ENSG00000106211 P04792 Heat shock protein beta-1 5 NX_P04792 HSPB1_HUMAN 3315 602195; 606595; 608634 HSPB1 Heat shock 27kDa protein 1 Evidence at protein level HPA000497, CAB004439, CAB047330, CAB047331, CAB047332 Expressed in all Plasma membrane<br>Cytosol NA esophagus: 1622.3 29 P04792 Heat shock protein beta-1 5 NX_P04792 HSPB1_HUMAN 3315 602195; 606595; 608634 ENSG00000106211 HSPB1 Heat shock 27kDa protein 1 Evidence at protein level HPA000497, CAB004439, CAB047330, CAB047331, CAB047332 Expressed in all Supported Validated Plasma membrane<br>Cytosol NA esophagus: 1622.3
30 ENSG00000108244; ENSG00000263309 Q9C075 Keratin, type I cytoskeletal 23 4 NX_Q9C075 K1C23_HUMAN 25984 606194 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 30 Q9C075 Keratin, type I cytoskeletal 23 4 NX_Q9C075 K1C23_HUMAN 25984 606194 ENSG00000108244 KRT23 Keratin 23, type I Evidence at protein level HPA012050, HPA016959, CAB017091 Tissue enhanced Approved Approved Intermediate filaments<br>Cytosol placenta: 68.3;skin: 71.0 salivary gland: 41.5
31 ENSG00000108578 Q13867 Bleomycin hydrolase 5 NX_Q13867 BLMH_HUMAN 642 602403 BLMH Bleomycin hydrolase Evidence at protein level HPA039548, HPA064307 Expressed in all Nucleoplasm<br>Nuclear bodies<br>Cytosol NA skin: 140.2 31 Q13867 Bleomycin hydrolase 5 NX_Q13867 BLMH_HUMAN 642 602403 ENSG00000108578 BLMH Bleomycin hydrolase Evidence at protein level HPA039548, HPA064307 Expressed in all Supported Supported Nucleoplasm<br>Nuclear bodies<br>Cytosol NA skin: 140.2
32 ENSG00000108953; ENSG00000274474 P62258 14-3-3 protein epsilon 4 NX_P62258 1433E_HUMAN 7531 605066 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 32 P62258 14-3-3 protein epsilon 4 NX_P62258 1433E_HUMAN 7531 605066 ENSG00000108953 YWHAE Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon Evidence at protein level HPA008445, CAB016200, CAB021109, CAB047350 Expressed in all Approved Uncertain Cytosol NA cerebral cortex: 452.9
33 ENSG00000109107 P09972 Fructose-bisphosphate aldolase C 2 NX_P09972 ALDOC_HUMAN 230 103870 ALDOC Aldolase C, fructose-bisphosphate Evidence at protein level HPA003282, CAB020828, HPA067442 Tissue enriched Nucleus<br>Nucleoli fibrillar center<br>Vesicles<br>Cytosol cerebral cortex: 768.7 heart muscle: 110.6 33 P09972 Fructose-bisphosphate aldolase C 2 NX_P09972 ALDOC_HUMAN 230 103870 ENSG00000109107 ALDOC Aldolase C, fructose-bisphosphate Evidence at protein level HPA003282, CAB020828, HPA067442 Tissue enriched Supported Approved Nucleus<br>Nucleoli fibrillar center<br>Vesicles<br>Cytosol cerebral cortex: 768.7 heart muscle: 110.6
34 ENSG00000109971 P11142 Heat shock cognate 71 kDa protein 5 NX_P11142 HSP7C_HUMAN 3312 600816 HSPA8 Heat shock 70kDa protein 8 Evidence at protein level CAB002056, HPA052504 Expressed in all Nucleoplasm<br>Vesicles NA cerebral cortex: 1122.1 34 P11142 Heat shock cognate 71 kDa protein 5 NX_P11142 HSP7C_HUMAN 3312 600816 ENSG00000109971 HSPA8 Heat shock 70kDa protein 8 Evidence at protein level CAB002056, HPA052504 Expressed in all Uncertain Uncertain Nucleoplasm<br>Vesicles NA cerebral cortex: 1122.1
35 ENSG00000111640 P04406 Glyceraldehyde-3-phosphate dehydrogenase 8 NX_P04406 G3P_HUMAN 2597 138400 GAPDH Glyceraldehyde-3-phosphate dehydrogenase Evidence at protein level CAB005197, CAB016392, HPA040067, HPA061280 Expressed in all Plasma membrane<br>Cytosol NA skeletal muscle: 9875.4 35 P04406 Glyceraldehyde-3-phosphate dehydrogenase 8 NX_P04406 G3P_HUMAN 2597 138400 ENSG00000111640 GAPDH Glyceraldehyde-3-phosphate dehydrogenase Evidence at protein level CAB005197, CAB016392, HPA040067, HPA061280 Expressed in all Supported Validated Plasma membrane<br>Cytosol NA skeletal muscle: 9875.4
36 ENSG00000111669 P60174 Triosephosphate isomerase 9 NX_P60174 TPIS_HUMAN 7167 190450; 615512 TPI1 Triosephosphate isomerase 1 Evidence at protein level HPA050924, HPA053568 Expressed in all Nucleoplasm NA skeletal muscle: 942.9 36 P60174 Triosephosphate isomerase 9 NX_P60174 TPIS_HUMAN 7167 190450; 615512 ENSG00000111669 TPI1 Triosephosphate isomerase 1 Evidence at protein level HPA050924, HPA053568 Expressed in all Uncertain Validated Nucleoplasm NA skeletal muscle: 942.9
37 ENSG00000112378 Q96FX8 p53 apoptosis effector related to PMP-22 2 NX_Q96FX8 PERP_HUMAN 64065 609301 PERP PERP, TP53 apoptosis effector Evidence at protein level HPA022269 Group enriched NA esophagus: 574.1;skin: 1238.6 breast: 149.6 37 Q96FX8 p53 apoptosis effector related to PMP-22 2 NX_Q96FX8 PERP_HUMAN 64065 609301 ENSG00000112378 PERP PERP, TP53 apoptosis effector Evidence at protein level HPA022269 Group enriched Supported NA NA esophagus: 574.1;skin: 1238.6 breast: 149.6
38 ENSG00000117450 Q06830 Peroxiredoxin-1 9 NX_Q06830 PRDX1_HUMAN 5052 176763 PRDX1 Peroxiredoxin 1 Evidence at protein level CAB004682, HPA007730 Expressed in all Mitochondria NA thyroid gland: 1203.6 38 Q06830 Peroxiredoxin-1 9 NX_Q06830 PRDX1_HUMAN 5052 176763 ENSG00000117450 PRDX1 Peroxiredoxin 1 Evidence at protein level CAB004682, HPA007730 Expressed in all Approved Supported Mitochondria NA thyroid gland: 1203.6
39 ENSG00000117983 Q9HC84 Mucin-5B 21 NX_Q9HC84 MUC5B_HUMAN 727897 178500; 600770 MUC5B Mucin 5B, oligomeric mucus/gel-forming Evidence at protein level HPA008246, CAB009396 Group enriched Vesicles cervix, uterine: 347.7;gallbladder: 346.8 colon: 32.6 39 Q9HC84 Mucin-5B 21 NX_Q9HC84 MUC5B_HUMAN 727897 178500; 600770 ENSG00000117983 MUC5B Mucin 5B, oligomeric mucus/gel-forming Evidence at protein level HPA008246, CAB009396 Group enriched Supported Validated Vesicles cervix, uterine: 347.7;gallbladder: 346.8 colon: 32.6
40 ENSG00000117984 P07339 Cathepsin D 6 NX_P07339 CATD_HUMAN 1509 116840; 610127 CTSD Cathepsin D Evidence at protein level CAB000109, HPA003001 Expressed in all NA NA lung: 1071.1 40 P07339 Cathepsin D 6 NX_P07339 CATD_HUMAN 1509 116840; 610127 ENSG00000117984 CTSD Cathepsin D Evidence at protein level CAB000109, HPA003001 Expressed in all Supported NA NA NA lung: 1071.1
41 ENSG00000118520 P05089 Arginase-1 8 NX_P05089 ARGI1_HUMAN 383 207800; 608313 ARG1 Arginase 1 Evidence at protein level HPA003595, CAB009434, HPA024006, CAB056159 Tissue enhanced NA bone marrow: 171.2;liver: 564.5 skin: 78.2 41 P05089 Arginase-1 8 NX_P05089 ARGI1_HUMAN 383 207800; 608313 ENSG00000118520 ARG1 Arginase 1 Evidence at protein level HPA003595, CAB009434, HPA024006, CAB056159 Tissue enhanced Supported NA NA bone marrow: 171.2;liver: 564.5 skin: 78.2
42 ENSG00000119655 P61916 Epididymal secretory protein E1 2 NX_P61916 NPC2_HUMAN 10577 601015; 607625 NPC2 Niemann-Pick disease, type C2 Evidence at protein level HPA000835 Tissue enriched NA epididymis: 16057.0 lung: 850.5 42 P61916 Epididymal secretory protein E1 2 NX_P61916 NPC2_HUMAN 10577 601015; 607625 ENSG00000119655 NPC2 Niemann-Pick disease, type C2 Evidence at protein level HPA000835 Tissue enriched Supported NA NA epididymis: 16057.0 lung: 850.5
43 ENSG00000119912 P14735 Insulin-degrading enzyme 3 NX_P14735 IDE_HUMAN 3416 146680 IDE Insulin-degrading enzyme Evidence at protein level HPA063478 Expressed in all NA NA skin: 63.5 43 P14735 Insulin-degrading enzyme 3 NX_P14735 IDE_HUMAN 3416 146680 ENSG00000119912 IDE Insulin-degrading enzyme Evidence at protein level HPA063478 Expressed in all Approved NA NA NA skin: 63.5
44 ENSG00000121316 Q6P4A8 Phospholipase B-like 1 5 NX_Q6P4A8 PLBL1_HUMAN 79887 NA PLBD1 Phospholipase B domain containing 1 Evidence at protein level HPA040303 Expressed in all NA NA bone marrow: 167.6 44 Q6P4A8 Phospholipase B-like 1 5 NX_Q6P4A8 PLBL1_HUMAN 79887 NA ENSG00000121316 PLBD1 Phospholipase B domain containing 1 Evidence at protein level HPA040303 Expressed in all Approved NA NA NA bone marrow: 167.6
45 ENSG00000121552 P01040 Cystatin-A 8 NX_P01040 CYTA_HUMAN 1475 184600; 607936 CSTA Cystatin A (stefin A) Evidence at protein level CAB000469, HPA001031, CAB047315 Group enriched Nucleus<br>Cytosol esophagus: 3891.8;tonsil: 868.8 skin: 429.9 45 P01040 Cystatin-A 8 NX_P01040 CYTA_HUMAN 1475 184600; 607936 ENSG00000121552 CSTA Cystatin A (stefin A) Evidence at protein level CAB000469, HPA001031, CAB047315 Group enriched Supported Uncertain Nucleus<br>Cytosol esophagus: 3891.8;tonsil: 868.8 skin: 429.9
46 ENSG00000121691 P04040 Catalase 9 NX_P04040 CATA_HUMAN 847 115500; 614097 CAT Catalase Evidence at protein level CAB001515, HPA051282, HPA055838 Expressed in all Vesicles<br>Cytosol NA liver: 624.4 46 P04040 Catalase 9 NX_P04040 CATA_HUMAN 847 115500; 614097 ENSG00000121691 CAT Catalase Evidence at protein level CAB001515, HPA051282, HPA055838 Expressed in all Supported Supported Vesicles<br>Cytosol NA liver: 624.4
47 ENSG00000123416 P68363 Tubulin alpha-1B chain 7 NX_P68363 TBA1B_HUMAN 10376 602530 TUBA1B Tubulin, alpha 1b Evidence at protein level CAB011513, HPA039247, HPA043684, HPA063394 Expressed in all Microtubules NA cerebral cortex: 1417.8 47 P68363 Tubulin alpha-1B chain 7 NX_P68363 TBA1B_HUMAN 10376 602530 ENSG00000123416 TUBA1B Tubulin, alpha 1b Evidence at protein level CAB011513, HPA039247, HPA043684, HPA063394 Expressed in all Supported Supported Microtubules NA cerebral cortex: 1417.8
48 ENSG00000124429 Q8WVV4 Protein POF1B 8 NX_Q8WVV4 POF1B_HUMAN 79983 300603; 300604 POF1B Premature ovarian failure, 1B Evidence at protein level HPA002033, HPA050027 Tissue enhanced Nucleoplasm<br>Golgi apparatus skin: 144.8 rectum: 53.7 48 Q8WVV4 Protein POF1B 8 NX_Q8WVV4 POF1B_HUMAN 79983 300603; 300604 ENSG00000124429 POF1B Premature ovarian failure, 1B Evidence at protein level HPA002033, HPA050027 Tissue enhanced Uncertain Supported Nucleoplasm<br>Golgi apparatus skin: 144.8 rectum: 53.7
49 ENSG00000124466 O95274 Ly6/PLAUR domain-containing protein 3 2 NX_O95274 LYPD3_HUMAN 27076 609484 LYPD3 LY6/PLAUR domain containing 3 Evidence at protein level HPA041529, HPA041797, HPA077859 Group enriched Endoplasmic reticulum<br>Vesicles esophagus: 676.5;skin: 594.5 tonsil: 118.9 49 O95274 Ly6/PLAUR domain-containing protein 3 2 NX_O95274 LYPD3_HUMAN 27076 609484 ENSG00000124466 LYPD3 LY6/PLAUR domain containing 3 Evidence at protein level HPA041529, HPA041797, HPA077859 Group enriched Supported Approved Endoplasmic reticulum<br>Vesicles esophagus: 676.5;skin: 594.5 tonsil: 118.9
50 ENSG00000125780 Q08188 Protein-glutamine gamma-glutamyltransferase E 12 NX_Q08188 TGM3_HUMAN 7053 600238; 617251 TGM3 Transglutaminase 3 Evidence at protein level HPA004728 Tissue enriched NA esophagus: 1519.7 tonsil: 131.7 50 Q08188 Protein-glutamine gamma-glutamyltransferase E 12 NX_Q08188 TGM3_HUMAN 7053 600238; 617251 ENSG00000125780 TGM3 Transglutaminase 3 Evidence at protein level HPA004728 Tissue enriched Approved NA NA esophagus: 1519.7 tonsil: 131.7
51 ENSG00000128422 Q04695 Keratin, type I cytoskeletal 17 18 NX_Q04695 K1C17_HUMAN 3872 148069; 167210; 184500 KRT17 Keratin 17, type I Evidence at protein level CAB000029, HPA000452, HPA000453, HPA000539, HPA045062 Tissue enhanced Intermediate filaments breast: 219.7;seminal vesicle: 223.4;urinary bladder: 334.2 prostate: 106.2 51 Q04695 Keratin, type I cytoskeletal 17 18 NX_Q04695 K1C17_HUMAN 3872 148069; 167210; 184500 ENSG00000128422 KRT17 Keratin 17, type I Evidence at protein level CAB000029, HPA000452, HPA000453, HPA000539, HPA045062 Tissue enhanced Supported Supported Intermediate filaments breast: 219.7;seminal vesicle: 223.4;urinary bladder: 334.2 prostate: 106.2
52 ENSG00000128510 Q9UI42 Carboxypeptidase A4 6 NX_Q9UI42 CBPA4_HUMAN 51200 607635 CPA4 Carboxypeptidase A4 Evidence at protein level HPA021030 Tissue enriched Nucleoplasm<br>Centrosome<br>Cytosol skin: 68.0 esophagus: 10.0 52 Q9UI42 Carboxypeptidase A4 6 NX_Q9UI42 CBPA4_HUMAN 51200 607635 ENSG00000128510 CPA4 Carboxypeptidase A4 Evidence at protein level HPA021030 Tissue enriched Uncertain Approved Nucleoplasm<br>Centrosome<br>Cytosol skin: 68.0 esophagus: 10.0
53 ENSG00000130402; ENSG00000282844 O43707 Alpha-actinin-4;Alpha-actinin-1 6 NX_O43707 ACTN4_HUMAN 81 603278; 604638 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 53 O43707 Alpha-actinin-4;Alpha-actinin-1 6 NX_O43707 ACTN4_HUMAN 81 603278; 604638 ENSG00000130402 ACTN4 Actinin, alpha 4 Evidence at protein level HPA001873, HPA006035 Expressed in all Supported Supported Nuclear bodies<br>Cytosol NA esophagus: 118.9
54 ENSG00000134333 P00338 L-lactate dehydrogenase A chain 6 NX_P00338 LDHA_HUMAN 3939 150000; 612933 LDHA Lactate dehydrogenase A Evidence at protein level CAB015336 Expressed in all Vesicles<br>Cytosol NA adipose tissue: 499.8 54 P00338 L-lactate dehydrogenase A chain 6 NX_P00338 LDHA_HUMAN 3939 150000; 612933 ENSG00000134333 LDHA Lactate dehydrogenase A Evidence at protein level CAB015336 Expressed in all Approved Supported Vesicles<br>Cytosol NA adipose tissue: 499.8
55 ENSG00000134760 Q02413 Desmoglein-1 24 NX_Q02413 DSG1_HUMAN 1828 125670; 148700; 615508 DSG1 Desmoglein 1 Evidence at protein level CAB009394, HPA022128 Tissue enriched NA skin: 727.4 esophagus: 36.5 55 Q02413 Desmoglein-1 24 NX_Q02413 DSG1_HUMAN 1828 125670; 148700; 615508 ENSG00000134760 DSG1 Desmoglein 1 Evidence at protein level CAB009394, HPA022128 Tissue enriched Supported NA NA skin: 727.4 esophagus: 36.5
56 ENSG00000134762 Q14574 Desmocollin-3 4 NX_Q14574 DSC3_HUMAN 1825 600271; 613102 DSC3 Desmocollin 3 Evidence at protein level CAB037328, HPA049265, HPA073937 Group enriched Plasma membrane<br>Cell Junctions esophagus: 119.5;skin: 455.7 tonsil: 25.9 56 Q14574 Desmocollin-3 4 NX_Q14574 DSC3_HUMAN 1825 600271; 613102 ENSG00000134762 DSC3 Desmocollin 3 Evidence at protein level CAB037328, HPA049265, HPA073937 Group enriched Supported Validated Plasma membrane<br>Cell Junctions esophagus: 119.5;skin: 455.7 tonsil: 25.9
57 ENSG00000135046 P04083 Annexin A1 10 NX_P04083 ANXA1_HUMAN 301 151690 ANXA1 Annexin A1 Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Tissue enriched Nucleoplasm<br>Plasma membrane<br>Cytosol esophagus: 7577.8 tonsil: 1266.5 57 P04083 Annexin A1 10 NX_P04083 ANXA1_HUMAN 301 151690 ENSG00000135046 ANXA1 Annexin A1 Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Tissue enriched Supported Validated Nucleoplasm<br>Plasma membrane<br>Cytosol esophagus: 7577.8 tonsil: 1266.5
58 ENSG00000136068 O75369 Filamin-B 5 NX_O75369 FLNB_HUMAN 2317 108720; 108721; 112310; 150250; 272460; 603381 FLNB Filamin B, beta Evidence at protein level HPA004747, HPA004886, CAB019322 Expressed in all Golgi apparatus<br>Plasma membrane<br>Actin filaments<br>Cytosol NA prostate: 161.4 58 O75369 Filamin-B 5 NX_O75369 FLNB_HUMAN 2317 108720; 108721; 112310; 150250; 272460; 603381 ENSG00000136068 FLNB Filamin B, beta Evidence at protein level HPA004747, HPA004886, CAB019322 Expressed in all Supported Supported Golgi apparatus<br>Plasma membrane<br>Actin filaments<br>Cytosol NA prostate: 161.4
59 ENSG00000136688 Q9NZH8 Interleukin-36 gamma 6 NX_Q9NZH8 IL36G_HUMAN 56300 605542 IL36G Interleukin 36, gamma Evidence at protein level NA Group enriched NA skin: 15.8;tonsil: 40.8 esophagus: 2.7 59 Q9NZH8 Interleukin-36 gamma 6 NX_Q9NZH8 IL36G_HUMAN 56300 605542 ENSG00000136688 IL36G Interleukin 36, gamma Evidence at protein level NA Group enriched NA NA NA skin: 15.8;tonsil: 40.8 esophagus: 2.7
60 ENSG00000136689 P18510 Interleukin-1 receptor antagonist protein 3 NX_P18510 IL1RA_HUMAN 3557 147679; 612628; 612852 IL1RN Interleukin 1 receptor antagonist Evidence at protein level HPA001482, CAB009633 Tissue enhanced NA esophagus: 1248.5 tonsil: 301.6 60 P18510 Interleukin-1 receptor antagonist protein 3 NX_P18510 IL1RA_HUMAN 3557 147679; 612628; 612852 ENSG00000136689 IL1RN Interleukin 1 receptor antagonist Evidence at protein level HPA001482, CAB009633 Tissue enhanced Supported NA NA esophagus: 1248.5 tonsil: 301.6
61 ENSG00000136810 P10599 Thioredoxin 6 NX_P10599 THIO_HUMAN 7295 187700 TXN Thioredoxin Evidence at protein level CAB008678, HPA047478, HPA055752 Expressed in all Nucleus<br>Nucleoli<br>Cytosol NA esophagus: 705.8 61 P10599 Thioredoxin 6 NX_P10599 THIO_HUMAN 7295 187700 ENSG00000136810 TXN Thioredoxin Evidence at protein level CAB008678, HPA047478, HPA055752 Expressed in all Supported Validated Nucleus<br>Nucleoli<br>Cytosol NA esophagus: 705.8
62 ENSG00000136943 O60911 Cathepsin L2 4 NX_O60911 CATL2_HUMAN 1515 603308 CTSV Cathepsin V Evidence at protein level CAB017112 Tissue enhanced Nucleus<br>Nucleoli fibrillar center<br>Plasma membrane<br>Cytosol cervix, uterine: 68.9;skin: 64.3;testis: 131.2 placenta: 25.7 62 O60911 Cathepsin L2 4 NX_O60911 CATL2_HUMAN 1515 603308 ENSG00000136943 CTSV Cathepsin V Evidence at protein level CAB017112 Tissue enhanced Uncertain Approved Nucleus<br>Nucleoli fibrillar center<br>Plasma membrane<br>Cytosol cervix, uterine: 68.9;skin: 64.3;testis: 131.2 placenta: 25.7
63 ENSG00000137563 Q92820 Gamma-glutamyl hydrolase 5 NX_Q92820 GGH_HUMAN 8836 601509 GGH Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) Evidence at protein level CAB019296, HPA025226 Tissue enhanced NA kidney: 89.2 liver: 62.8 63 Q92820 Gamma-glutamyl hydrolase 5 NX_Q92820 GGH_HUMAN 8836 601509 ENSG00000137563 GGH Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) Evidence at protein level CAB019296, HPA025226 Tissue enhanced Approved NA NA kidney: 89.2 liver: 62.8
64 ENSG00000138071 P61160 Actin-related protein 2 2 NX_P61160 ARP2_HUMAN 10097 604221 ACTR2 ARP2 actin-related protein 2 homolog (yeast) Evidence at protein level CAB005083, HPA015050 Expressed in all Cytosol NA appendix: 300.7 64 P61160 Actin-related protein 2 2 NX_P61160 ARP2_HUMAN 10097 604221 ENSG00000138071 ACTR2 ARP2 actin-related protein 2 homolog (yeast) Evidence at protein level CAB005083, HPA015050 Expressed in all Approved Approved Cytosol NA appendix: 300.7
65 ENSG00000142168 P00441 Superoxide dismutase [Cu-Zn] 5 NX_P00441 SODC_HUMAN 6647 105400; 147450 SOD1 Superoxide dismutase 1, soluble Evidence at protein level HPA001401, CAB008670 Expressed in all Nucleus<br>Plasma membrane<br>Cytosol NA liver: 767.7 65 P00441 Superoxide dismutase [Cu-Zn] 5 NX_P00441 SODC_HUMAN 6647 105400; 147450 ENSG00000142168 SOD1 Superoxide dismutase 1, soluble Evidence at protein level HPA001401, CAB008670 Expressed in all Supported Supported Nucleus<br>Plasma membrane<br>Cytosol NA liver: 767.7
66 ENSG00000143556 P31151 Protein S100-A7 9 NX_P31151 S10A7_HUMAN 6278 600353 S100A7 S100 calcium binding protein A7 Evidence at protein level CAB001453, HPA006997, CAB033766 Group enriched NA skin: 325.1;tonsil: 921.8 esophagus: 96.4 66 P31151 Protein S100-A7 9 NX_P31151 S10A7_HUMAN 6278 600353 ENSG00000143556 S100A7 S100 calcium binding protein A7 Evidence at protein level CAB001453, HPA006997, CAB033766 Group enriched Supported NA NA skin: 325.1;tonsil: 921.8 esophagus: 96.4
67 ENSG00000143631 P20930 Filaggrin 2 NX_P20930 FILA_HUMAN 2312 135940; 146700; 605803 FLG Filaggrin Evidence at protein level CAB002210, HPA027505, HPA030188, HPA030189 Tissue enriched Vesicles skin: 549.7 breast: 21.0 67 P20930 Filaggrin 2 NX_P20930 FILA_HUMAN 2312 135940; 146700; 605803 ENSG00000143631 FLG Filaggrin Evidence at protein level CAB002210, HPA027505, HPA030188, HPA030189 Tissue enriched Supported Supported Vesicles skin: 549.7 breast: 21.0
68 ENSG00000146701 P40926 Malate dehydrogenase, mitochondrial 3 NX_P40926 MDHM_HUMAN 4191 154100; 617339 MDH2 Malate dehydrogenase 2, NAD (mitochondrial) Evidence at protein level HPA019714, HPA019716, HPA019848, HPA026720 Expressed in all Mitochondria NA skeletal muscle: 233.3 68 P40926 Malate dehydrogenase, mitochondrial 3 NX_P40926 MDHM_HUMAN 4191 154100; 617339 ENSG00000146701 MDH2 Malate dehydrogenase 2, NAD (mitochondrial) Evidence at protein level HPA019714, HPA019716, HPA019848, HPA026720 Expressed in all Supported Validated Mitochondria NA skeletal muscle: 233.3
69 ENSG00000148180 P06396 Gelsolin 3 NX_P06396 GELS_HUMAN 2934 105120; 137350 GSN Gelsolin Evidence at protein level CAB010823, CAB016728, CAB036009, HPA054026 Expressed in all Actin filaments NA adipose tissue: 1336.6 69 P06396 Gelsolin 3 NX_P06396 GELS_HUMAN 2934 105120; 137350 ENSG00000148180 GSN Gelsolin Evidence at protein level CAB010823, CAB016728, CAB036009, HPA054026 Expressed in all Supported Supported Actin filaments NA adipose tissue: 1336.6
70 ENSG00000148346 P80188 Neutrophil gelatinase-associated lipocalin 3 NX_P80188 NGAL_HUMAN 3934 600181 LCN2 Lipocalin 2 Evidence at protein level HPA002695, CAB016549, CAB016550 Tissue enhanced NA bone marrow: 1855.7;gallbladder: 3437.6 cervix: 1153.6 70 P80188 Neutrophil gelatinase-associated lipocalin 3 NX_P80188 NGAL_HUMAN 3934 600181 ENSG00000148346 LCN2 Lipocalin 2 Evidence at protein level HPA002695, CAB016549, CAB016550 Tissue enhanced Supported NA NA bone marrow: 1855.7;gallbladder: 3437.6 cervix: 1153.6
71 ENSG00000149273 P23396 40S ribosomal protein S3 2 NX_P23396 RS3_HUMAN 6188 600454 RPS3 Ribosomal protein S3 Evidence at protein level HPA063339 Expressed in all Endoplasmic reticulum<br>Cytosol NA ovary: 3526.1 71 P23396 40S ribosomal protein S3 2 NX_P23396 RS3_HUMAN 6188 600454 ENSG00000149273 RPS3 Ribosomal protein S3 Evidence at protein level HPA063339 Expressed in all Uncertain Supported Endoplasmic reticulum<br>Cytosol NA ovary: 3526.1
72 ENSG00000149925 P04075 Fructose-bisphosphate aldolase A 4 NX_P04075 ALDOA_HUMAN 226 103850; 611881 ALDOA Aldolase A, fructose-bisphosphate Evidence at protein level HPA004177, CAB006252 Tissue enriched Cytosol skeletal muscle: 9379.1 esophagus: 1434.9 72 P04075 Fructose-bisphosphate aldolase A 4 NX_P04075 ALDOA_HUMAN 226 103850; 611881 ENSG00000149925 ALDOA Aldolase A, fructose-bisphosphate Evidence at protein level HPA004177, CAB006252 Tissue enriched Supported Supported Cytosol skeletal muscle: 9379.1 esophagus: 1434.9
73 ENSG00000152234 P25705 ATP synthase subunit alpha, mitochondrial 2 NX_P25705 ATPA_HUMAN 498 164360; 615228; 616045 ATP5A1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle Evidence at protein level CAB013067, HPA040622, HPA044202 Expressed in all Mitochondria NA parathyroid gland: 853.0 73 P25705 ATP synthase subunit alpha, mitochondrial 2 NX_P25705 ATPA_HUMAN 498 164360; 615228; 616045 ENSG00000152234 ATP5A1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle Evidence at protein level CAB013067, HPA040622, HPA044202 Expressed in all Supported Supported Mitochondria NA parathyroid gland: 853.0
74 ENSG00000159763 P12273 Prolactin-inducible protein 6 NX_P12273 PIP_HUMAN 5304 176720 PIP Prolactin-induced protein Evidence at protein level CAB002661, HPA009177 Group enriched NA breast: 4413.0;salivary gland: 6961.2;seminal vesicle: 4142.4 prostate: 93.4 74 P12273 Prolactin-inducible protein 6 NX_P12273 PIP_HUMAN 5304 176720 ENSG00000159763 PIP Prolactin-induced protein Evidence at protein level CAB002661, HPA009177 Group enriched Supported NA NA breast: 4413.0;salivary gland: 6961.2;seminal vesicle: 4142.4 prostate: 93.4
75 ENSG00000160213 P04080 Cystatin-B 2 NX_P04080 CYTB_HUMAN 1476 254800; 601145 CSTB Cystatin B (stefin B) Evidence at protein level HPA017380, CAB047320, HPA058557 Tissue enriched Nucleoli<br>Cytosol esophagus: 1836.3 tonsil: 237.3 75 P04080 Cystatin-B 2 NX_P04080 CYTB_HUMAN 1476 254800; 601145 ENSG00000160213 CSTB Cystatin B (stefin B) Evidence at protein level HPA017380, CAB047320, HPA058557 Tissue enriched Supported Supported Nucleoli<br>Cytosol esophagus: 1836.3 tonsil: 237.3
76 ENSG00000160349 P31025 Lipocalin-1 4 NX_P31025 LCN1_HUMAN 3933 151675 LCN1 Lipocalin 1 Evidence at protein level NA Group enriched NA fallopian tube: 3.0;seminal vesicle: 12.1 prostate: 1.4 76 P31025 Lipocalin-1 4 NX_P31025 LCN1_HUMAN 3933 151675 ENSG00000160349 LCN1 Lipocalin 1 Evidence at protein level NA Group enriched NA NA NA fallopian tube: 3.0;seminal vesicle: 12.1 prostate: 1.4
77 ENSG00000160789 P02545 Prelamin-A/C;Lamin-A/C 10 NX_P02545 LMNA_HUMAN 4000 115200; 150330; 151660; 159001; 176670; 181350; 212112; 248370; 275210; 605588; 610140; 613205; 616516 LMNA Lamin A/C Evidence at protein level CAB004022, HPA006660 Expressed in all NA NA gallbladder: 344.5 77 P02545 Prelamin-A/C;Lamin-A/C 10 NX_P02545 LMNA_HUMAN 4000 115200; 150330; 151660; 159001; 176670; 181350; 212112; 248370; 275210; 605588; 610140; 613205; 616516 ENSG00000160789 LMNA Lamin A/C Evidence at protein level CAB004022, HPA006660 Expressed in all Supported NA NA NA gallbladder: 344.5
78 ENSG00000160862 P25311 Zinc-alpha-2-glycoprotein 15 NX_P25311 ZA2G_HUMAN 563 194460 AZGP1 Alpha-2-glycoprotein 1, zinc-binding Evidence at protein level HPA012582, CAB016087, CAB032276 Tissue enhanced NA breast: 1188.3;liver: 1270.8;prostate: 1556.6;salivary gland: 1431.4 kidney: 292.6 78 P25311 Zinc-alpha-2-glycoprotein 15 NX_P25311 ZA2G_HUMAN 563 194460 ENSG00000160862 AZGP1 Alpha-2-glycoprotein 1, zinc-binding Evidence at protein level HPA012582, CAB016087, CAB032276 Tissue enhanced Supported NA NA breast: 1188.3;liver: 1270.8;prostate: 1556.6;salivary gland: 1431.4 kidney: 292.6
79 ENSG00000161960 P60842 Eukaryotic initiation factor 4A-I 5 NX_P60842 IF4A1_HUMAN 1973 602641 EIF4A1 Eukaryotic translation initiation factor 4A1 Evidence at protein level CAB011689, HPA068286 Expressed in all Cytosol NA smooth muscle: 452.3 79 P60842 Eukaryotic initiation factor 4A-I 5 NX_P60842 IF4A1_HUMAN 1973 602641 ENSG00000161960 EIF4A1 Eukaryotic translation initiation factor 4A1 Evidence at protein level CAB011689, HPA068286 Expressed in all Uncertain Approved Cytosol NA smooth muscle: 452.3
80 ENSG00000162078; ENSG00000283056 Q96DA0 Zymogen granule protein 16 homolog B 5 NX_Q96DA0 ZG16B_HUMAN 124220 NA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 80 Q96DA0 Zymogen granule protein 16 homolog B 5 NX_Q96DA0 ZG16B_HUMAN 124220 NA ENSG00000162078 ZG16B Zymogen granule protein 16B Evidence at protein level HPA041125, HPA053549 Tissue enriched Supported Approved Nucleoplasm<br>Vesicles salivary gland: 19669.3 prostate: 93.6
81 ENSG00000162896 P01833 Polymeric immunoglobulin receptor 15 NX_P01833 PIGR_HUMAN 5284 173880 PIGR Polymeric immunoglobulin receptor Evidence at protein level HPA006154, CAB009454, HPA012012 Tissue enhanced Nucleus<br>Nucleoli<br>Cytosol colon: 1721.7;duodenum: 2732.8 rectum: 1357.3 81 P01833 Polymeric immunoglobulin receptor 15 NX_P01833 PIGR_HUMAN 5284 173880 ENSG00000162896 PIGR Polymeric immunoglobulin receptor Evidence at protein level HPA006154, CAB009454, HPA012012 Tissue enhanced Supported Uncertain Nucleus<br>Nucleoli<br>Cytosol colon: 1721.7;duodenum: 2732.8 rectum: 1357.3
82 ENSG00000163191 P31949 Protein S100-A11 2 NX_P31949 S10AB_HUMAN 6282 603114 S100A11 S100 calcium binding protein A11 Evidence at protein level CAB034320, HPA042745 Expressed in all NA NA esophagus: 2733.4 82 P31949 Protein S100-A11 2 NX_P31949 S10AB_HUMAN 6282 603114 ENSG00000163191 S100A11 S100 calcium binding protein A11 Evidence at protein level CAB034320, HPA042745 Expressed in all Supported NA NA NA esophagus: 2733.4
83 ENSG00000163631 P02768 Serum albumin 44 NX_P02768 ALBU_HUMAN 213 103600; 615999; 616000 ALB Albumin Evidence at protein level CAB006262, HPA031024, HPA031025 Tissue enriched Endoplasmic reticulum<br>Golgi apparatus liver: 105632.0 kidney: 478.5 83 P02768 Serum albumin 44 NX_P02768 ALBU_HUMAN 213 103600; 615999; 616000 ENSG00000163631 ALB Albumin Evidence at protein level CAB006262, HPA031024, HPA031025 Tissue enriched Supported Validated Endoplasmic reticulum<br>Golgi apparatus liver: 105632.0 kidney: 478.5
84 ENSG00000164687 Q01469 Fatty acid-binding protein 5, epidermal 15 NX_Q01469 FABP5_HUMAN 2171 605168 FABP5 Fatty acid binding protein 5 (psoriasis-associated) Evidence at protein level CAB017831, CAB040577, HPA051895 Expressed in all Plasma membrane<br>Cytosol NA esophagus: 1671.2 84 Q01469 Fatty acid-binding protein 5, epidermal 15 NX_Q01469 FABP5_HUMAN 2171 605168 ENSG00000164687 FABP5 Fatty acid binding protein 5 (psoriasis-associated) Evidence at protein level CAB017831, CAB040577, HPA051895 Expressed in all Supported Supported Plasma membrane<br>Cytosol NA esophagus: 1671.2
85 ENSG00000164733 P07858 Cathepsin B 2 NX_P07858 CATB_HUMAN 1508 116810 CTSB Cathepsin B Evidence at protein level CAB000457, HPA018156 Expressed in all Nucleoli<br>Vesicles NA thyroid gland: 2885.5 85 P07858 Cathepsin B 2 NX_P07858 CATB_HUMAN 1508 116810 ENSG00000164733 CTSB Cathepsin B Evidence at protein level CAB000457, HPA018156 Expressed in all Uncertain Supported Nucleoli<br>Vesicles NA thyroid gland: 2885.5
86 ENSG00000164924 P63104 14-3-3 protein zeta/delta 5 NX_P63104 1433Z_HUMAN 7534 601288 YWHAZ Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta Evidence at protein level CAB005065 Expressed in all NA NA esophagus: 928.6 86 P63104 14-3-3 protein zeta/delta 5 NX_P63104 1433Z_HUMAN 7534 601288 ENSG00000164924 YWHAZ Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta Evidence at protein level CAB005065 Expressed in all Approved NA NA NA esophagus: 928.6
87 ENSG00000166396 O75635 Serpin B7 7 NX_O75635 SPB7_HUMAN 8710 603357; 615598 SERPINB7 Serpin peptidase inhibitor, clade B (ovalbumin), member 7 Evidence at protein level HPA024200 Tissue enhanced Endoplasmic reticulum<br>Mitochondria skin: 123.8;tonsil: 35.5 breast: 17.2 87 O75635 Serpin B7 7 NX_O75635 SPB7_HUMAN 8710 603357; 615598 ENSG00000166396 SERPINB7 Serpin peptidase inhibitor, clade B (ovalbumin), member 7 Evidence at protein level HPA024200 Tissue enhanced Approved Approved Endoplasmic reticulum<br>Mitochondria skin: 123.8;tonsil: 35.5 breast: 17.2
88 ENSG00000166535 A8K2U0 Alpha-2-macroglobulin-like protein 1 3 NX_A8K2U0 A2ML1_HUMAN 144568 610627 A2ML1 Alpha-2-macroglobulin-like 1 Evidence at protein level HPA038847, HPA038848 Tissue enriched NA esophagus: 480.8 skin: 85.7 88 A8K2U0 Alpha-2-macroglobulin-like protein 1 3 NX_A8K2U0 A2ML1_HUMAN 144568 610627 ENSG00000166535 A2ML1 Alpha-2-macroglobulin-like 1 Evidence at protein level HPA038847, HPA038848 Tissue enriched Supported NA NA esophagus: 480.8 skin: 85.7
89 ENSG00000166634 Q96P63 Serpin B12 9 NX_Q96P63 SPB12_HUMAN 89777 615662 SERPINB12 Serpin peptidase inhibitor, clade B (ovalbumin), member 12 Evidence at protein level NA Tissue enriched NA skin: 78.4 esophagus: 15.2 89 Q96P63 Serpin B12 9 NX_Q96P63 SPB12_HUMAN 89777 615662 ENSG00000166634 SERPINB12 Serpin peptidase inhibitor, clade B (ovalbumin), member 12 Evidence at protein level NA Tissue enriched NA NA NA skin: 78.4 esophagus: 15.2
90 ENSG00000166794 P23284 Peptidyl-prolyl cis-trans isomerase B 2 NX_P23284 PPIB_HUMAN 5479 123841; 259440 PPIB Peptidylprolyl isomerase B (cyclophilin B) Evidence at protein level CAB011487, HPA012720 Expressed in all Nucleus<br>Endoplasmic reticulum NA thyroid gland: 852.0 90 P23284 Peptidyl-prolyl cis-trans isomerase B 2 NX_P23284 PPIB_HUMAN 5479 123841; 259440 ENSG00000166794 PPIB Peptidylprolyl isomerase B (cyclophilin B) Evidence at protein level CAB011487, HPA012720 Expressed in all Supported Supported Nucleus<br>Endoplasmic reticulum NA thyroid gland: 852.0
91 ENSG00000167658 P13639 Elongation factor 2 8 NX_P13639 EF2_HUMAN 1938 130610; 609306 EEF2 Eukaryotic translation elongation factor 2 Evidence at protein level CAB007795, HPA040534, HPA057351 Expressed in all Plasma membrane<br>Cytosol NA ovary: 1621.9 91 P13639 Elongation factor 2 8 NX_P13639 EF2_HUMAN 1938 130610; 609306 ENSG00000167658 EEF2 Eukaryotic translation elongation factor 2 Evidence at protein level CAB007795, HPA040534, HPA057351 Expressed in all Approved Validated Plasma membrane<br>Cytosol NA ovary: 1621.9
92 ENSG00000167748 P06870 Kallikrein-1 2 NX_P06870 KLK1_HUMAN 3816 147910; 615953 KLK1 Kallikrein 1 Evidence at protein level NA Group enriched NA pancreas: 1994.3;salivary gland: 2571.5 colon: 64.8 92 P06870 Kallikrein-1 2 NX_P06870 KLK1_HUMAN 3816 147910; 615953 ENSG00000167748 KLK1 Kallikrein 1 Evidence at protein level NA Group enriched NA NA NA pancreas: 1994.3;salivary gland: 2571.5 colon: 64.8
93 ENSG00000167767 Q6KB66 Keratin, type II cytoskeletal 80 13 NX_Q6KB66 K2C80_HUMAN 144501 611161 KRT80 Keratin 80, type II Evidence at protein level HPA077836, HPA077918 Tissue enhanced Intermediate filaments skin: 125.3 tonsil: 39.1 93 Q6KB66 Keratin, type II cytoskeletal 80 13 NX_Q6KB66 K2C80_HUMAN 144501 611161 ENSG00000167767 KRT80 Keratin 80, type II Evidence at protein level HPA077836, HPA077918 Tissue enhanced NA Validated Intermediate filaments skin: 125.3 tonsil: 39.1
94 ENSG00000168028 P08865 40S ribosomal protein SA 2 NX_P08865 RSSA_HUMAN 3921 150370; 271400 RPSA Ribosomal protein SA Evidence at protein level CAB009561 Expressed in all Plasma membrane<br>Cytosol NA ovary: 2079.5 94 P08865 40S ribosomal protein SA 2 NX_P08865 RSSA_HUMAN 3921 150370; 271400 ENSG00000168028 RPSA Ribosomal protein SA Evidence at protein level CAB009561 Expressed in all Approved Supported Plasma membrane<br>Cytosol NA ovary: 2079.5
95 ENSG00000169469 P22528 Cornifin-B 3 NX_P22528 SPR1B_HUMAN 6699 182266 SPRR1B Small proline-rich protein 1B Evidence at protein level NA Tissue enriched NA esophagus: 2466.0 tonsil: 422.7 95 P22528 Cornifin-B 3 NX_P22528 SPR1B_HUMAN 6699 182266 ENSG00000169469 SPRR1B Small proline-rich protein 1B Evidence at protein level NA Tissue enriched NA NA NA esophagus: 2466.0 tonsil: 422.7
96 ENSG00000170369 P09228 Cystatin-SA 2 NX_P09228 CYTT_HUMAN 1470 123856 CST2 Cystatin SA Evidence at protein level CAB024963, HPA043706, HPA044763 Tissue enriched NA salivary gland: 2062.3 gallbladder: 7.3 96 P09228 Cystatin-SA 2 NX_P09228 CYTT_HUMAN 1470 123856 ENSG00000170369 CST2 Cystatin SA Evidence at protein level CAB024963, HPA043706, HPA044763 Tissue enriched Supported NA NA salivary gland: 2062.3 gallbladder: 7.3
97 ENSG00000170373 P01037 Cystatin-SN 2 NX_P01037 CYTN_HUMAN 1469 123855 CST1 Cystatin SN Evidence at protein level CAB026769, HPA043706, HPA044763 Tissue enriched NA salivary gland: 9637.4 gallbladder: 354.6 97 P01037 Cystatin-SN 2 NX_P01037 CYTN_HUMAN 1469 123855 ENSG00000170373 CST1 Cystatin SN Evidence at protein level CAB026769, HPA043706, HPA044763 Tissue enriched Supported NA NA salivary gland: 9637.4 gallbladder: 354.6
98 ENSG00000170423 Q8N1N4 Keratin, type II cytoskeletal 78 18 NX_Q8N1N4 K2C78_HUMAN 196374 611159 KRT78 Keratin 78, type II Evidence at protein level HPA039724 Tissue enriched NA esophagus: 1058.9 tonsil: 132.4 98 Q8N1N4 Keratin, type II cytoskeletal 78 18 NX_Q8N1N4 K2C78_HUMAN 196374 611159 ENSG00000170423 KRT78 Keratin 78, type II Evidence at protein level HPA039724 Tissue enriched Supported NA NA esophagus: 1058.9 tonsil: 132.4
99 ENSG00000170477 P19013 Keratin, type II cytoskeletal 4 13 NX_P19013 K2C4_HUMAN NA 123940; 193900 KRT4 Keratin 4, type II Evidence at protein level CAB002154, HPA034881 Tissue enriched Intermediate filaments esophagus: 14911.0 tonsil: 623.1 99 P19013 Keratin, type II cytoskeletal 4 13 NX_P19013 K2C4_HUMAN NA 123940; 193900 ENSG00000170477 KRT4 Keratin 4, type II Evidence at protein level CAB002154, HPA034881 Tissue enriched Supported Validated Intermediate filaments esophagus: 14911.0 tonsil: 623.1
100 ENSG00000171195 Q8TAX7 Mucin-7 2 NX_Q8TAX7 MUC7_HUMAN 4589 158375; 600807 MUC7 Mucin 7, secreted Evidence at protein level HPA006411 Tissue enriched NA salivary gland: 11456.2 ovary: 7.7 100 Q8TAX7 Mucin-7 2 NX_Q8TAX7 MUC7_HUMAN 4589 158375; 600807 ENSG00000171195 MUC7 Mucin 7, secreted Evidence at protein level HPA006411 Tissue enriched Supported NA NA salivary gland: 11456.2 ovary: 7.7
101 ENSG00000171346 P19012 Keratin, type I cytoskeletal 15 2 NX_P19012 K1C15_HUMAN 3866 148030 KRT15 Keratin 15, type I Evidence at protein level HPA023910, HPA024554 Group enriched Nucleoplasm<br>Intermediate filaments breast: 320.0;esophagus: 787.5;skin: 1012.3 prostate: 84.8 101 P19012 Keratin, type I cytoskeletal 15 2 NX_P19012 K1C15_HUMAN 3866 148030 ENSG00000171346 KRT15 Keratin 15, type I Evidence at protein level HPA023910, HPA024554 Group enriched Supported Supported Nucleoplasm<br>Intermediate filaments breast: 320.0;esophagus: 787.5;skin: 1012.3 prostate: 84.8
102 ENSG00000171401 P13646 Keratin, type I cytoskeletal 13 11 NX_P13646 K1C13_HUMAN 3860 148065; 615785 KRT13 Keratin 13, type I Evidence at protein level CAB000133, HPA030877 Tissue enriched Intermediate filaments esophagus: 35268.3 tonsil: 1800.1 102 P13646 Keratin, type I cytoskeletal 13 11 NX_P13646 K1C13_HUMAN 3860 148065; 615785 ENSG00000171401 KRT13 Keratin 13, type I Evidence at protein level CAB000133, HPA030877 Tissue enriched Supported Validated Intermediate filaments esophagus: 35268.3 tonsil: 1800.1
103 ENSG00000173801 P14923 Junction plakoglobin 22 NX_P14923 PLAK_HUMAN 3728 173325; 601214; 611528 JUP Junction plakoglobin Evidence at protein level CAB002139, HPA032047 Group enriched Vesicles<br>Plasma membrane<br>Cell Junctions esophagus: 493.6;skin: 787.3 fallopian tube: 112.6 103 P14923 Junction plakoglobin 22 NX_P14923 PLAK_HUMAN 3728 173325; 601214; 611528 ENSG00000173801 JUP Junction plakoglobin Evidence at protein level CAB002139, HPA032047 Group enriched Supported Validated Vesicles<br>Plasma membrane<br>Cell Junctions esophagus: 493.6;skin: 787.3 fallopian tube: 112.6
104 ENSG00000174876; ENSG00000187733; ENSG00000237763 P04745 Alpha-amylase 1 23 NX_P04745 AMY1_HUMAN 276; 277; 278 104700; 104701; 104702 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 104 P04745 Alpha-amylase 1 23 NX_P04745 AMY1_HUMAN 276; 277; 278 104700; 104701; 104702 ENSG00000174876 AMY1B Amylase, alpha 1B (salivary) Evidence at protein level HPA045394, HPA045399, HPA046980 Tissue enriched Supported NA NA salivary gland: 1847.5 cervix: 125.1
105 ENSG00000175315 Q15828 Cystatin-M 3 NX_Q15828 CYTM_HUMAN 1474 601891 CST6 Cystatin E/M Evidence at protein level CAB019316, HPA044963 Tissue enriched Plasma membrane<br>Cytosol skin: 213.3 breast: 24.7 105 Q15828 Cystatin-M 3 NX_Q15828 CYTM_HUMAN 1474 601891 ENSG00000175315 CST6 Cystatin E/M Evidence at protein level CAB019316, HPA044963 Tissue enriched Supported Approved Plasma membrane<br>Cytosol skin: 213.3 breast: 24.7
106 ENSG00000175793 P31947 14-3-3 protein sigma 9 NX_P31947 1433S_HUMAN 2810 601290 SFN Stratifin Evidence at protein level CAB006268, HPA011105, CAB040552 Group enriched Cytosol esophagus: 1094.4;skin: 1158.9 tonsil: 137.8 106 P31947 14-3-3 protein sigma 9 NX_P31947 1433S_HUMAN 2810 601290 ENSG00000175793 SFN Stratifin Evidence at protein level CAB006268, HPA011105, CAB040552 Group enriched Supported Supported Cytosol esophagus: 1094.4;skin: 1158.9 tonsil: 137.8
107 ENSG00000178209 Q15149 Plectin 15 NX_Q15149 PLEC_HUMAN 5339 131950; 226670; 601282; 612138; 613723; 616487 PLEC Plectin Evidence at protein level CAB003847, HPA025967, HPA029906 Expressed in all Intermediate filaments<br>Focal adhesion sites<br>Cytosol NA skeletal muscle: 94.9 107 Q15149 Plectin 15 NX_Q15149 PLEC_HUMAN 5339 131950; 226670; 601282; 612138; 613723; 616487 ENSG00000178209 PLEC Plectin Evidence at protein level CAB003847, HPA025967, HPA029906 Expressed in all Supported Validated Intermediate filaments<br>Focal adhesion sites<br>Cytosol NA skeletal muscle: 94.9
108 ENSG00000178363 P27482 Calmodulin-like protein 3 2 NX_P27482 CALL3_HUMAN 810 114184 CALML3 Calmodulin-like 3 Evidence at protein level CAB010070, HPA044999 Tissue enhanced NA esophagus: 166.4;skin: 42.7 tonsil: 23.4 108 P27482 Calmodulin-like protein 3 2 NX_P27482 CALL3_HUMAN 810 114184 ENSG00000178363 CALML3 Calmodulin-like 3 Evidence at protein level CAB010070, HPA044999 Tissue enhanced Approved NA NA esophagus: 166.4;skin: 42.7 tonsil: 23.4
109 ENSG00000178372 Q9NZT1 Calmodulin-like protein 5 8 NX_Q9NZT1 CALL5_HUMAN 51806 605183 CALML5 Calmodulin-like 5 Evidence at protein level HPA040725 Group enriched Plasma membrane<br>Cytosol salivary gland: 262.7;skin: 651.2 breast: 55.1 109 Q9NZT1 Calmodulin-like protein 5 8 NX_Q9NZT1 CALL5_HUMAN 51806 605183 ENSG00000178372 CALML5 Calmodulin-like 5 Evidence at protein level HPA040725 Group enriched Supported Approved Plasma membrane<br>Cytosol salivary gland: 262.7;skin: 651.2 breast: 55.1
110 ENSG00000178934; ENSG00000205076; ENSG00000282902; ENSG00000283082 P47929 Galectin-7 5 NX_P47929 LEG7_HUMAN 3963; 653499 600615; 617139 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 110 P47929 Galectin-7 5 NX_P47929 LEG7_HUMAN 3963; 653499 600615; 617139 ENSG00000178934 LGALS7B Lectin, galactoside-binding, soluble, 7B Evidence at protein level HPA001549, CAB025100 Tissue enhanced Supported NA NA breast: 10.2;esophagus: 19.4 skeletal muscle: 3.8
111 ENSG00000179477 O75342 Arachidonate 12-lipoxygenase, 12R-type 4 NX_O75342 LX12B_HUMAN 242 242100; 603741 ALOX12B Arachidonate 12-lipoxygenase, 12R type Evidence at protein level HPA024002 Group enriched Cytosol skin: 70.1;tonsil: 18.1 esophagus: 6.2 111 O75342 Arachidonate 12-lipoxygenase, 12R-type 4 NX_O75342 LX12B_HUMAN 242 242100; 603741 ENSG00000179477 ALOX12B Arachidonate 12-lipoxygenase, 12R type Evidence at protein level HPA024002 Group enriched Supported Approved Cytosol skin: 70.1;tonsil: 18.1 esophagus: 6.2
112 ENSG00000182718 P07355 Annexin A2;Putative annexin A2-like protein 22 NX_P07355 ANXA2_HUMAN 302 151740 ANXA2 Annexin A2 Evidence at protein level CAB004311 Expressed in all NA NA esophagus: 1494.3 112 P07355 Annexin A2;Putative annexin A2-like protein 22 NX_P07355 ANXA2_HUMAN 302 151740 ENSG00000182718 ANXA2 Annexin A2 Evidence at protein level CAB004311 Expressed in all Approved NA NA NA esophagus: 1494.3
113 ENSG00000184009 P63261 Actin, cytoplasmic 2 19 NX_P63261 ACTG_HUMAN 71 102560; 604717; 614583 ACTG1 Actin gamma 1 Evidence at protein level HPA041264, HPA041271 Expressed in all NA NA ovary: 2398.3 113 P63261 Actin, cytoplasmic 2 19 NX_P63261 ACTG_HUMAN 71 102560; 604717; 614583 ENSG00000184009 ACTG1 Actin gamma 1 Evidence at protein level HPA041264, HPA041271 Expressed in all Approved NA NA NA ovary: 2398.3
114 ENSG00000185479 P04259 Keratin, type II cytoskeletal 6B 10 NX_P04259 K2C6B_HUMAN 3854 148042; 615728 KRT6B Keratin 6B, type II Evidence at protein level CAB000130, HPA045697, HPA061168 Tissue enriched Intermediate filaments esophagus: 673.4 tonsil: 69.9 114 P04259 Keratin, type II cytoskeletal 6B 10 NX_P04259 K2C6B_HUMAN 3854 148042; 615728 ENSG00000185479 KRT6B Keratin 6B, type II Evidence at protein level CAB000130, HPA045697, HPA061168 Tissue enriched Supported Approved Intermediate filaments esophagus: 673.4 tonsil: 69.9
115 ENSG00000185896 P11279 Lysosome-associated membrane glycoprotein 1 2 NX_P11279 LAMP1_HUMAN 3916 153330 LAMP1 Lysosomal-associated membrane protein 1 Evidence at protein level CAB004260, HPA014750 Expressed in all NA NA thyroid gland: 210.9 115 P11279 Lysosome-associated membrane glycoprotein 1 2 NX_P11279 LAMP1_HUMAN 3916 153330 ENSG00000185896 LAMP1 Lysosomal-associated membrane protein 1 Evidence at protein level CAB004260, HPA014750 Expressed in all Supported NA NA NA thyroid gland: 210.9
116 ENSG00000186832 P08779 Keratin, type I cytoskeletal 16 29 NX_P08779 K1C16_HUMAN 3868 148067; 167200; 613000 KRT16 Keratin 16, type I Evidence at protein level CAB000136, HPA000539 Group enriched Intermediate filaments esophagus: 479.6;tonsil: 106.5 seminal vesicle: 52.4 116 P08779 Keratin, type I cytoskeletal 16 29 NX_P08779 K1C16_HUMAN 3868 148067; 167200; 613000 ENSG00000186832 KRT16 Keratin 16, type I Evidence at protein level CAB000136, HPA000539 Group enriched Approved Uncertain Intermediate filaments esophagus: 479.6;tonsil: 106.5 seminal vesicle: 52.4
117 ENSG00000187908 Q9UGM3 Deleted in malignant brain tumors 1 protein 6 NX_Q9UGM3 DMBT1_HUMAN 1755 137800; 601969 DMBT1 Deleted in malignant brain tumors 1 Evidence at protein level HPA040778 Tissue enhanced NA duodenum: 876.2;small intestine: 299.5 salivary gland: 145.2 117 P04745 Alpha-amylase 1 23 NX_P04745 AMY1_HUMAN 276; 277; 278 104700; 104701; 104702 ENSG00000187733 AMY1C Amylase, alpha 1C (salivary) Evidence at protein level HPA045394, HPA045399, HPA046980 Tissue enhanced Supported NA NA cervix, uterine: 32.6;salivary gland: 102.5 pancreas: 26.4
118 ENSG00000188229 P68371 Tubulin beta-4B chain 8 NX_P68371 TBB4B_HUMAN 10383 602660 TUBB4B Tubulin, beta 4B class IVb Evidence at protein level CAB010880, HPA043640, HPA046280 Expressed in all Microtubules NA testis: 787.0 118 Q9UGM3 Deleted in malignant brain tumors 1 protein 6 NX_Q9UGM3 DMBT1_HUMAN 1755 137800; 601969 ENSG00000187908 DMBT1 Deleted in malignant brain tumors 1 Evidence at protein level HPA040778 Tissue enhanced Supported NA NA duodenum: 876.2;small intestine: 299.5 salivary gland: 145.2
119 ENSG00000189001 Q6UWP8 Suprabasin 4 NX_Q6UWP8 SBSN_HUMAN 374897 609969 SBSN Suprabasin Evidence at protein level HPA062568, HPA067734 Group enriched Vesicles esophagus: 1059.9;skin: 2694.5 tonsil: 158.2 119 P68371 Tubulin beta-4B chain 8 NX_P68371 TBB4B_HUMAN 10383 602660 ENSG00000188229 TUBB4B Tubulin, beta 4B class IVb Evidence at protein level CAB010880, HPA043640, HPA046280 Expressed in all Supported Validated Microtubules NA testis: 787.0
120 ENSG00000189058 P05090 Apolipoprotein D 2 NX_P05090 APOD_HUMAN 347 107740 APOD Apolipoprotein D Evidence at protein level HPA040520 Tissue enriched NA breast: 4546.8 adipose tissue: 668.0 120 Q6UWP8 Suprabasin 4 NX_Q6UWP8 SBSN_HUMAN 374897 609969 ENSG00000189001 SBSN Suprabasin Evidence at protein level HPA062568, HPA067734 Group enriched Supported Approved Vesicles esophagus: 1059.9;skin: 2694.5 tonsil: 158.2
121 ENSG00000189334 Q9HCY8 Protein S100-A14 3 NX_Q9HCY8 S10AE_HUMAN 57402 607986 S100A14 S100 calcium binding protein A14 Evidence at protein level HPA027613 Tissue enhanced Nuclear bodies<br>Cell Junctions<br>Cytosol esophagus: 2214.5 skin: 592.3 121 P05090 Apolipoprotein D 2 NX_P05090 APOD_HUMAN 347 107740 ENSG00000189058 APOD Apolipoprotein D Evidence at protein level HPA040520 Tissue enriched Supported NA NA breast: 4546.8 adipose tissue: 668.0
122 ENSG00000196136 P01011 Alpha-1-antichymotrypsin 3 NX_P01011 AACT_HUMAN 12 107280 SERPINA3 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 Evidence at protein level HPA000893, HPA002560, CAB016647 Group enriched NA cervix, uterine: 133.1;liver: 607.5 gallbladder: 69.4 122 Q9HCY8 Protein S100-A14 3 NX_Q9HCY8 S10AE_HUMAN 57402 607986 ENSG00000189334 S100A14 S100 calcium binding protein A14 Evidence at protein level HPA027613 Tissue enhanced Supported Supported Nuclear bodies<br>Cell Junctions<br>Cytosol esophagus: 2214.5 skin: 592.3
123 ENSG00000196262 P62937 Peptidyl-prolyl cis-trans isomerase A 5 NX_P62937 PPIA_HUMAN 5478 123840 PPIA Peptidylprolyl isomerase A (cyclophilin A) Evidence at protein level CAB004655, HPA058345 Expressed in all NA NA breast: 1666.2 123 P01011 Alpha-1-antichymotrypsin 3 NX_P01011 AACT_HUMAN 12 107280 ENSG00000196136 SERPINA3 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 Evidence at protein level HPA000893, HPA002560, CAB016647 Group enriched Supported NA NA cervix, uterine: 133.1;liver: 607.5 gallbladder: 69.4
124 ENSG00000197249 P01009 Alpha-1-antitrypsin;Short peptide from AAT 6 NX_P01009 A1AT_HUMAN 5265 107400; 613490 SERPINA1 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 Evidence at protein level HPA000927, HPA001292, CAB013211, CAB016648, CAB073396 Tissue enriched Vesicles liver: 15340.0 lung: 799.2 124 P62937 Peptidyl-prolyl cis-trans isomerase A 5 NX_P62937 PPIA_HUMAN 5478 123840 ENSG00000196262 PPIA Peptidylprolyl isomerase A (cyclophilin A) Evidence at protein level CAB004655, HPA058345 Expressed in all Uncertain NA NA NA breast: 1666.2
125 ENSG00000197641 Q9UIV8 Serpin B13 2 NX_Q9UIV8 SPB13_HUMAN 5275 604445 SERPINB13 Serpin peptidase inhibitor, clade B (ovalbumin), member 13 Evidence at protein level HPA052630, HPA057129 Tissue enriched Nuclear speckles<br>Cytosol esophagus: 185.3 tonsil: 21.6 125 P01009 Alpha-1-antitrypsin;Short peptide from AAT 6 NX_P01009 A1AT_HUMAN 5265 107400; 613490 ENSG00000197249 SERPINA1 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 Evidence at protein level HPA000927, HPA001292, CAB013211, CAB016648, CAB073396 Tissue enriched Supported Validated Vesicles liver: 15340.0 lung: 799.2
126 ENSG00000197915 Q86YZ3 Hornerin 11 NX_Q86YZ3 HORN_HUMAN 388697 616293 HRNR Hornerin Evidence at protein level HPA031469 Not detected Mitochondria NA skin: 0.7 126 Q9UIV8 Serpin B13 2 NX_Q9UIV8 SPB13_HUMAN 5275 604445 ENSG00000197641 SERPINB13 Serpin peptidase inhibitor, clade B (ovalbumin), member 13 Evidence at protein level HPA052630, HPA057129 Tissue enriched Supported Approved Nuclear speckles<br>Cytosol esophagus: 185.3 tonsil: 21.6
127 ENSG00000198805 P00491 Purine nucleoside phosphorylase 2 NX_P00491 PNPH_HUMAN 4860 164050; 613179 PNP Purine nucleoside phosphorylase Evidence at protein level HPA001625 Expressed in all NA NA epididymis: 686.0 127 Q86YZ3 Hornerin 11 NX_Q86YZ3 HORN_HUMAN 388697 616293 ENSG00000197915 HRNR Hornerin Evidence at protein level HPA031469 Not detected Uncertain Approved Mitochondria NA skin: 0.7
128 ENSG00000198854 Q5T750 Skin-specific protein 32 4 NX_Q5T750 XP32_HUMAN 100129271 NA C1orf68 Chromosome 1 open reading frame 68 Evidence at protein level HPA040836 Tissue enriched NA skin: 807.2 breast: 56.7 128 P00491 Purine nucleoside phosphorylase 2 NX_P00491 PNPH_HUMAN 4860 164050; 613179 ENSG00000198805 PNP Purine nucleoside phosphorylase Evidence at protein level HPA001625 Expressed in all Supported NA NA NA epididymis: 686.0
129 ENSG00000204388; ENSG00000224501; ENSG00000212866; ENSG00000231555; ENSG00000232804 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 129 Q5T750 Skin-specific protein 32 4 NX_Q5T750 XP32_HUMAN 100129271 NA ENSG00000198854 C1orf68 Chromosome 1 open reading frame 68 Evidence at protein level HPA040836 Tissue enriched Uncertain NA NA skin: 807.2 breast: 56.7
130 ENSG00000205420 P02538 Keratin, type II cytoskeletal 6A 53 NX_P02538 K2C6A_HUMAN 3853 148041; 615726 KRT6A Keratin 6A, type II Evidence at protein level HPA045697, HPA061168 Tissue enriched Intermediate filaments esophagus: 5726.3 tonsil: 585.8 130 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 ENSG00000204388 HSPA1B Heat shock 70kDa protein 1B Evidence at protein level CAB008640, HPA052504 Tissue enhanced Approved Uncertain Nucleoplasm<br>Vesicles adrenal gland: 34.3 urinary bladder: 15.0
131 ENSG00000206073 P48594 Serpin B4 4 NX_P48594 SPB4_HUMAN 6318 600518 SERPINB4 Serpin peptidase inhibitor, clade B (ovalbumin), member 4 Evidence at protein level HPA048341, HPA049988, HPA055992 Group enriched NA esophagus: 98.6;urinary bladder: 20.1 skin: 9.4 131 P47929 Galectin-7 5 NX_P47929 LEG7_HUMAN 3963; 653499 600615; 617139 ENSG00000205076 LGALS7 Lectin, galactoside-binding, soluble, 7 Evidence at protein level HPA001549, CAB032606 Group enriched Supported NA NA breast: 17.9;esophagus: 24.4;skin: 27.7 skeletal muscle: 3.6
132 ENSG00000206075 P36952 Serpin B5 3 NX_P36952 SPB5_HUMAN 5268 154790 SERPINB5 Serpin peptidase inhibitor, clade B (ovalbumin), member 5 Evidence at protein level CAB009570, HPA019025, HPA019132, HPA020136 Group enriched Vesicles esophagus: 221.1;skin: 262.5 breast: 43.8 132 P02538 Keratin, type II cytoskeletal 6A 53 NX_P02538 K2C6A_HUMAN 3853 148041; 615726 ENSG00000205420 KRT6A Keratin 6A, type II Evidence at protein level HPA045697, HPA061168 Tissue enriched Supported Approved Intermediate filaments esophagus: 5726.3 tonsil: 585.8
133 ENSG00000211890 P01877 Ig alpha-2 chain C region 3 NX_P01877 IGHA2_HUMAN NA 147000 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 133 P48594 Serpin B4 4 NX_P48594 SPB4_HUMAN 6318 600518 ENSG00000206073 SERPINB4 Serpin peptidase inhibitor, clade B (ovalbumin), member 4 Evidence at protein level HPA048341, HPA049988, HPA055992 Group enriched Supported NA NA esophagus: 98.6;urinary bladder: 20.1 skin: 9.4
134 ENSG00000211895; ENSG00000282633 P01876 Ig alpha-1 chain C region 16 NX_P01876 IGHA1_HUMAN NA 146900 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 134 P36952 Serpin B5 3 NX_P36952 SPB5_HUMAN 5268 154790 ENSG00000206075 SERPINB5 Serpin peptidase inhibitor, clade B (ovalbumin), member 5 Evidence at protein level CAB009570, HPA019025, HPA019132, HPA020136 Group enriched Supported Supported Vesicles esophagus: 221.1;skin: 262.5 breast: 43.8
135 ENSG00000211896; ENSG00000277633 P01857 Ig gamma-1 chain C region 7 NX_P01857 IGHG1_HUMAN NA 147100; 254500 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 135 P01877 Ig alpha-2 chain C region 3 NX_P01877 IGHA2_HUMAN NA 147000 ENSG00000211890 NA NA NA NA NA NA NA NA NA NA
136 ENSG00000211899; ENSG00000282657 P01871 Ig mu chain C region 2 NX_P01871 IGHM_HUMAN NA 147020; 601495 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 136 P01876 Ig alpha-1 chain C region 16 NX_P01876 IGHA1_HUMAN NA 146900 ENSG00000211895 NA NA NA NA NA NA NA NA NA NA
137 ENSG00000211942; ENSG00000282286 P01766 Ig heavy chain V-III region BRO 2 NX_P01766 HV313_HUMAN NA NA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 137 P01857 Ig gamma-1 chain C region 7 NX_P01857 IGHG1_HUMAN NA 147100; 254500 ENSG00000211896 NA NA NA NA NA NA NA NA NA NA
138 ENSG00000221983 P62987 Ubiquitin-60S ribosomal protein L40 6 NX_P62987 RL40_HUMAN 7311 191321 UBA52 Ubiquitin A-52 residue ribosomal protein fusion product 1 Evidence at protein level HPA041344, HPA049132, HPA056624 Expressed in all Nucleoplasm<br>Endoplasmic reticulum<br>Plasma membrane<br>Cytosol NA ovary: 1909.1 138 P01871 Ig mu chain C region 2 NX_P01871 IGHM_HUMAN NA 147020; 601495 ENSG00000211899 NA NA NA NA NA NA NA NA NA NA
139 ENSG00000229314 P02763 Alpha-1-acid glycoprotein 1 3 NX_P02763 A1AG1_HUMAN 5004 138600 ORM1 Orosomucoid 1 Evidence at protein level CAB006265, HPA046438, HPA047725, HPA057726 Tissue enriched Golgi apparatus<br>Vesicles liver: 10546.0 bone marrow: 152.7 139 P01766 Ig heavy chain V-III region BRO 2 NX_P01766 HV313_HUMAN NA NA ENSG00000211942 NA NA NA NA NA NA NA NA NA NA
140 ENSG00000241553 P59998 Actin-related protein 2/3 complex subunit 4 2 NX_P59998 ARPC4_HUMAN 10093 604226 ARPC4 Actin related protein 2/3 complex, subunit 4, 20kDa Evidence at protein level NA Expressed in all NA NA lymph node: 167.0 140 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 ENSG00000212866 NA NA NA NA NA NA NA NA NA NA
141 ENSG00000244734 P68871 Hemoglobin subunit beta 4 NX_P68871 HBB_HUMAN 3043 140700; 141900; 603902; 603903; 611162; 613985 HBB Hemoglobin, beta Evidence at protein level CAB009526, HPA043234 Tissue enriched NA bone marrow: 78261.0 placenta: 8978.3 141 P62987 Ubiquitin-60S ribosomal protein L40 6 NX_P62987 RL40_HUMAN 7311 191321 ENSG00000221983 UBA52 Ubiquitin A-52 residue ribosomal protein fusion product 1 Evidence at protein level HPA041344, HPA049132, HPA056624 Expressed in all Supported Approved Nucleoplasm<br>Endoplasmic reticulum<br>Plasma membrane<br>Cytosol NA ovary: 1909.1
142 ENSG00000254772 P26641 Elongation factor 1-gamma 3 NX_P26641 EF1G_HUMAN 1937 130593 EEF1G Eukaryotic translation elongation factor 1 gamma Evidence at protein level HPA040688 Expressed in all Mitochondria NA ovary: 2987.8 142 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 ENSG00000224501 NA NA NA NA NA NA NA NA NA NA
143 ENSG00000257017 P00738 Haptoglobin 3 NX_P00738 HPT_HUMAN 3240 140100; 614081 HP Haptoglobin Evidence at protein level CAB003787, HPA047750 Tissue enriched Vesicles liver: 28321.0 bone marrow: 156.1 143 P02763 Alpha-1-acid glycoprotein 1 3 NX_P02763 A1AG1_HUMAN 5004 138600 ENSG00000229314 ORM1 Orosomucoid 1 Evidence at protein level CAB006265, HPA046438, HPA047725, HPA057726 Tissue enriched Approved Approved Golgi apparatus<br>Vesicles liver: 10546.0 bone marrow: 152.7
144 ENSG00000277791; ENSG00000275903 P49720 Proteasome subunit beta type-3 2 NX_P49720 PSB3_HUMAN 5691 602176 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 144 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 ENSG00000231555 NA NA NA NA NA NA NA NA NA NA
145 ENSG00000281123 Q9Y6R7 IgGFc-binding protein 3 NX_Q9Y6R7 FCGBP_HUMAN 8857 617553 Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA Protein not found in HPA 145 P0DMV9 Heat shock 70 kDa protein 1B 8 NX_P0DMV9 HS71B_HUMAN 3303; 3304 140550; 603012 ENSG00000232804 NA NA NA NA NA NA NA NA NA NA
146 NA P01834 Ig kappa chain C region 8 NX_P01834 IGKC_HUMAN NA 147200; 614102 GRPEL2 NA NA NA NA NA NA NA 146 P04745 Alpha-amylase 1 23 NX_P04745 AMY1_HUMAN 276; 277; 278 104700; 104701; 104702 ENSG00000237763 AMY1A Amylase, alpha 1A (salivary) Evidence at protein level CAB004310, HPA045394, HPA045399, HPA046980 Tissue enriched Supported NA NA salivary gland: 8907.0 cervix: 111.5
147 NA P01860 Ig gamma-3 chain C region 2 NX_P01860 IGHG3_HUMAN NA 147120 GRPEL2 NA NA NA NA NA NA NA 147 P59998 Actin-related protein 2/3 complex subunit 4 2 NX_P59998 ARPC4_HUMAN 10093 604226 ENSG00000241553 ARPC4 Actin related protein 2/3 complex, subunit 4, 20kDa Evidence at protein level NA Expressed in all NA NA NA NA lymph node: 167.0
148 NA P58107 Epiplakin 5 NX_P58107 EPIPL_HUMAN 83481 607553 GRPEL2 NA NA NA NA NA NA NA 148 P68871 Hemoglobin subunit beta 4 NX_P68871 HBB_HUMAN 3043 140700; 141900; 603902; 603903; 611162; 613985 ENSG00000244734 HBB Hemoglobin, beta Evidence at protein level CAB009526, HPA043234 Tissue enriched Supported NA NA bone marrow: 78261.0 placenta: 8978.3
149 NA P01625 Ig kappa chain V-IV region Len 2 NA NA NA NA GRPEL2 NA NA NA NA NA NA NA 149 P26641 Elongation factor 1-gamma 3 NX_P26641 EF1G_HUMAN 1937 130593 ENSG00000254772 EEF1G Eukaryotic translation elongation factor 1 gamma Evidence at protein level HPA040688 Expressed in all Approved Approved Mitochondria NA ovary: 2987.8
150 NA P0CG05 Ig lambda-2 chain C regions 4 NA NA NA NA GRPEL2 NA NA NA NA NA NA NA 150 P00738 Haptoglobin 3 NX_P00738 HPT_HUMAN 3240 140100; 614081 ENSG00000257017 HP Haptoglobin Evidence at protein level CAB003787, HPA047750 Tissue enriched Supported Approved Vesicles liver: 28321.0 bone marrow: 156.1
151 NA P01623 Ig kappa chain V-III region 3 NA NA NA NA GRPEL2 NA NA NA NA NA NA NA 151 Q9C075 Keratin, type I cytoskeletal 23 4 NX_Q9C075 K1C23_HUMAN 25984 606194 ENSG00000263309 NA NA NA NA NA NA NA NA NA NA
152 NA P01765 Ig heavy chain V-III region TIL 2 NA NA NA NA GRPEL2 NA NA NA NA NA NA NA 152 P62258 14-3-3 protein epsilon 4 NX_P62258 1433E_HUMAN 7531 605066 ENSG00000274474 NA NA NA NA NA NA NA NA NA NA
153 P49720 Proteasome subunit beta type-3 2 NX_P49720 PSB3_HUMAN 5691 602176 ENSG00000275903 NA NA NA NA NA NA NA NA NA NA
154 P01857 Ig gamma-1 chain C region 7 NX_P01857 IGHG1_HUMAN NA 147100; 254500 ENSG00000277633 NA NA NA NA NA NA NA NA NA NA
155 P49720 Proteasome subunit beta type-3 2 NX_P49720 PSB3_HUMAN 5691 602176 ENSG00000277791 PSMB3 Proteasome subunit beta 3 Evidence at protein level HPA042775, HPA048147 Expressed in all Supported NA NA NA epididymis: 82.2
156 Q9Y6R7 IgGFc-binding protein 3 NX_Q9Y6R7 FCGBP_HUMAN 8857 617553 ENSG00000281123 NA NA NA NA NA NA NA NA NA NA
157 P01766 Ig heavy chain V-III region BRO 2 NX_P01766 HV313_HUMAN NA NA ENSG00000282286 NA NA NA NA NA NA NA NA NA NA
158 P01876 Ig alpha-1 chain C region 16 NX_P01876 IGHA1_HUMAN NA 146900 ENSG00000282633 NA NA NA NA NA NA NA NA NA NA
159 P01871 Ig mu chain C region 2 NX_P01871 IGHM_HUMAN NA 147020; 601495 ENSG00000282657 NA NA NA NA NA NA NA NA NA NA
160 O43707 Alpha-actinin-4;Alpha-actinin-1 6 NX_O43707 ACTN4_HUMAN 81 603278; 604638 ENSG00000282844 NA NA NA NA NA NA NA NA NA NA
161 P47929 Galectin-7 5 NX_P47929 LEG7_HUMAN 3963; 653499 600615; 617139 ENSG00000282902 NA NA NA NA NA NA NA NA NA NA
162 Q96DA0 Zymogen granule protein 16 homolog B 5 NX_Q96DA0 ZG16B_HUMAN 124220 NA ENSG00000283056 NA NA NA NA NA NA NA NA NA NA
163 P47929 Galectin-7 5 NX_P47929 LEG7_HUMAN 3963; 653499 600615; 617139 ENSG00000283082 NA NA NA NA NA NA NA NA NA NA
164 P01834 Ig kappa chain C region 8 NX_P01834 IGKC_HUMAN NA 147200; 614102 NA NA NA NA NA NA NA NA NA NA NA
165 P01625 Ig kappa chain V-IV region Len 2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
166 P01765 Ig heavy chain V-III region TIL 2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
167 P0CG05 Ig lambda-2 chain C regions 4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
168 P58107 Epiplakin 5 NX_P58107 EPIPL_HUMAN 83481 607553 NA NA NA NA NA NA NA NA NA NA NA
169 P01860 Ig gamma-3 chain C region 2 NX_P01860 IGHG3_HUMAN NA 147120 NA NA NA NA NA NA NA NA NA NA NA
170 P01623 Ig kappa chain V-III region 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA